ConductScience.org, home

Paper10074183

Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.

Verschoor EJ and 11 others. J Virol, 1999. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance. Papers, record 10074183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10074183

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.
PubMed
Journal
J Virol
PubMed
Year
1999
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
1.26
iCite
Revised in PubMed
2020-07-24
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Verschoor EJE J
2Mooij PP
3Oostermeijer HH
4van der Kolk MM
5ten Haaft PP
6Verstrepen BB
7Sun YY
8Morein BB
9Akerblom LL
10Fuller DHD H
11Barnett SWS W
12Heeney JLJ L

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AIDS VaccinesMajor topic
Acquired Immunodeficiency SyndromeMajor topic
HIV Envelope Protein gp120Major topic
HIV-1Major topic
ISCOMsMajor topic
Immunity, CellularMajor topic
PolysorbatesMajor topic
SqualeneMajor topic
Adjuvants, Immunologic
Animals
Chemistry, Pharmaceutical
Humans
Macaca mulatta
Recombinant Proteins

Source PubMed

Download CSV of topics

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11718036Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120.Science1991https://conductscience.org/library/papers/1718036PubMed
29325017In vivo and in vitro induction of IL-6 by Quillaja saponaria molina triterpenoid formulations.Cytokine1997https://conductscience.org/library/papers/9325017PubMed
31727480Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons.J Virol1992https://conductscience.org/library/papers/1727480PubMed
41613662Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins.J Acquir Immune Defic Syndr (1988)1992https://conductscience.org/library/papers/1613662PubMed
58456302Heterologous protection against influenza by injection of DNA encoding a viral protein.Science1993https://conductscience.org/library/papers/8456302PubMed
68176640Long-standing protection of macaques against cell-free HIV-2 with a HIV-2 iscom vaccine.J Acquir Immune Defic Syndr (1988)1994https://conductscience.org/library/papers/8176640PubMed
78046353Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells.J Exp Med1994https://conductscience.org/library/papers/8046353PubMed
87930610Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants.J Immunol1994https://conductscience.org/library/papers/7930610PubMed
97998425HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees.Vaccine1994https://conductscience.org/library/papers/7998425PubMed
109345075Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.N Engl J Med1997https://conductscience.org/library/papers/9345075PubMed
119367954Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.Science1997https://conductscience.org/library/papers/9367954PubMed
129543435A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection.AIDS1998https://conductscience.org/library/papers/9543435PubMed
139585194Why do we not have an HIV vaccine and how can we make one? .Nat Med1998https://conductscience.org/library/papers/9585194PubMed
149585205HIV vaccines--where are we going?Nat Med1998https://conductscience.org/library/papers/9585205PubMed
159747943The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protection.J Med Primatol1998https://conductscience.org/library/papers/9747943PubMed
169795387A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2.Vaccine1998https://conductscience.org/library/papers/9795387PubMed
179811776A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques.J Virol1998https://conductscience.org/library/papers/9811776PubMed
187865283Mechanisms behind the immune response induced by immunostimulating complexes.AIDS Res Hum Retroviruses1994https://conductscience.org/library/papers/7865283PubMed
197888198A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine.AIDS Res Hum Retroviruses1994https://conductscience.org/library/papers/7888198PubMed
207638218Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV).Proc Natl Acad Sci U S A1995https://conductscience.org/library/papers/7638218PubMed

See all 55 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
27880897Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env Trimer.Cell Rep2016https://conductscience.org/library/papers/27880897PubMed
24670321Modulation of HIV-1 immunity by adjuvants.Curr Opin HIV AIDS2014https://conductscience.org/library/papers/24670321PubMed
22595192MF59 formulated with CpG ODN as a potent adjuvant of recombinant HSP65-MUC1 for inducing anti-MUC1+ tumor immunity in mice.Int Immunopharmacol2012https://conductscience.org/library/papers/22595192PubMed
22291921Elicitation of neutralizing antibodies directed against CD4-induced epitope(s) using a CD4 mimetic cross-linked to a HIV-1 envelope glycoprotein.PLoS One2012https://conductscience.org/library/papers/22291921PubMed
22216149Protection in macaques immunized with HIV-1 candidate vaccines can be predicted using the kinetics of their neutralizing antibodies.PLoS One2011https://conductscience.org/library/papers/22216149PubMed
20872839Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.Wiley Interdiscip Rev Nanomed Nanobiotechnol2011https://conductscience.org/library/papers/20872839PubMed
19895847The ABC of clinical and experimental adjuvants--a brief overview.Immunol Lett2010https://conductscience.org/library/papers/19895847PubMed
19321617
Improved survival in rhesus macaques immunized with modified vaccinia virus Ankara recombinants expressing simian immunodeficiency virus envelope correlates with reduction in memory CD4+ T-cell loss and higher titers of neutralizing antibody.
J Virol2009https://conductscience.org/library/papers/19321617PubMed
15016855Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection.J Virol2004https://conductscience.org/library/papers/15016855PubMed
15008967
Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.
Clin Exp Immunol2004https://conductscience.org/library/papers/15008967PubMed
14641916Generating neutralizing antibodies, Th1 response and MHC non restricted immunogenicity of HIV-I env and gag peptides in liposomes and ISCOMs with in-built adjuvanticity.J Immune Based Ther Vaccines2003https://conductscience.org/library/papers/14641916PubMed
14557642Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge.J Virol2003https://conductscience.org/library/papers/14557642PubMed
11925610Construction and characterization of an experimental ISCOMS-based hepatitis B polypeptide vaccine.World J Gastroenterol2002https://conductscience.org/library/papers/11925610PubMed
10756013Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy.J Virol2000https://conductscience.org/library/papers/10756013PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10074183

GET https://conductscience.org/api/papers/v1/10074183/references?page=2